Preoperative Treatment of Locally Advanced Rectal CancerDeborah Schrag, Harvey J. Mamon, Qian Shi et al.|New England Journal of Medicine|2023Cited by 440
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaperArvind Dasari, Scott Kopetz, Cathy Eng et al.|Nature Reviews Clinical Oncology|2020Cited by 365
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)Ethan Basch, Deborah Schrag, Amylou C. Dueck et al.|Journal of Clinical Oncology|2023Cited by 136
Incorporation of lateral microfiltration with immunoaffinity for enhancing the capture efficiency of rare cellsKangfu Chen, Z. Hugh Fan, Jacob Amontree et al.|Scientific Reports|2020Cited by 28
PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).Deborah Schrag, Harvey J. Mamon, Qian Shi et al.|Journal of Clinical Oncology|2023Cited by 18